PureTech Health PLC at JPMorgan Healthcare Conference Transcript
Hi, everyone, and welcome to the 41st Annual JPMorgan Healthcare Conference. My name is Natalie Collins, and I'm an associate in the JPMorgan Healthcare Investment Banking team. Just a reminder, we'll have 20 minutes presentation format, followed by 20 minutes of Q&A. And with that, I'm thrilled to introduce the CEO, Daphne Zohar, and the CMO, Julie Krop of PureTech Health.
Thanks so much, Natalie. Thank you to JPMorgan for inviting us to present here today, and welcome to all of you who are joining us here in person. It's great to see so many friends and colleagues this week. Also welcome to everyone who's joining via webcast.
For those of you who are not familiar with PureTech, we're a new kind of biopharmaceutical company. And we're coming off of the back of a very successful 2022, where we had 5 clinical readouts. We're on the cusp of a major evolution in our company. And this year, we're going to have a number of important milestones, including the results of a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |